A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myocardial infarction

Cardiovascular Research

Volumn 71, Issue 4, 2006, Pages 744-753

  Gavira, Juan José ^a   Perez Ilzarbe, Maitane ^a   Abizanda, Gloria ^a   García Rodríguez, Alba ^d   Orbe, Josune ^c   Páramo, José Antonio ^a,c   Belzunce, Miriam ^c   Rábago, Gregorio ^a   Barba, Joaquín ^a   Herreros, Jesús ^a   Panizo, Angel ^b   de Jalón, José A García ^d   Martínez Caro, Diego ^a   Prósper, Felipe ^a,c  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

^d UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Cell therapy; Fibrosis; Myocardial infarction; Skeletal myoblasts; Vasculogenesis

Indexed keywords

BROXURIDINE; COLLAGEN TYPE 1; COLLAGEN TYPE 3;

ANGIOGENESIS; ANIMAL MODEL; ARTICLE; AUTOTRANSPLANTATION; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FIBROSIS; FLUOROSCOPY; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; IMMUNOHISTOCHEMISTRY; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SWINE;

ACTINS; ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; COLLAGEN; ECHOCARDIOGRAPHY; FIBROSIS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; MODELS, ANIMAL; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; SWINE; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 33751574491     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.06.018     Document Type: Article

References (42)

1. Murry C.E., Field L.J., and Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 112 (2005) 3174-3183
2. Menasche P. Skeletal muscle satellite cell transplantation. Cardiovasc Res 58 (2003) 351-357
3. Taylor D.A., Silvestry S.C., Bishop S.P., Annex B.H., Lilly R.E., Glower D.D., et al. Delivery of primary autologous skeletal myoblasts into rabbit heart by coronary infusion: a potential approach to myocardial repair. Proc Assoc Am Physicians 109 (1997) 245-253
4. Murry C.E., Wiseman R.W., Schwartz S.M., and Hauschka S.D. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 98 (1996) 2512-2523
5. Pouzet B., Vilquin J.T., Hagege A.A., Scorsin M., Messas E., Fiszman M., et al. Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann Thorac Surg 71 (2001) 844-850 [discussion 50-1]
6. Rajnoch C., Chachques J.C., Berrebi A., Bruneval P., Benoit M.O., and Carpentier A. Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg 121 (2001) 871-878
7. Ghostine S., Carrion C., Souza L.C., Richard P., Bruneval P., Vilquin J.T., et al. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 106 (2002) I131-I136
8. Menasche P., Hagege A.A., Vilquin J.-.T., Desnos M., Abergel E., Pouzet B., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41 (2003) 1078-1083
9. Menasche P., Hagege A.A., Scorsin M., Pouzet B., Desnos M., Duboc D., et al. Myoblast transplantation for heart failure. Lancet 357 (2001) 279-280
10. Herreros J., Prosper F., Perez A., Gavira J.J., Garcia-Velloso M.J., Barba J., et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 24 (2003) 2012-2020
11. Smits P.C., van Geuns R.J., Poldermans D., Bountioukos M., Onderwater E.E., Lee C.H., et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 42 (2003) 2063-2069
12. Siminiak T., Kalawski R., Fiszer D., Jerzykowska O., Rzezniczak J., Rozwadowska N., et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 148 (2004) 531-537
13. Reinecke H., Poppa V., and Murry C.E. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 34 (2002) 241-249
14. Reinecke H., MacDonald G.H., Hauschka S.D., and Murry C.E. Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J Cell Biol 149 (2000) 731-740
15. Reinecke H., Minami E., Poppa V., and Murry C.E. Evidence for fusion between cardiac and skeletal muscle cells. Circ Res 94 (2004) e56-e60
16. Suzuki K., Murtuza B., Smolenski R.T., Sammut I.A., Suzuki N., Kaneda Y., et al. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 104 (2001) I207-I212
17. Thum T., Bauersachs J., Poole-Wilson P.A., Volk H.D., and Anker S.D. The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol 46 (2005) 1799-1802
18. Suzuki K., Murtuza B., Beauchamp J.R., Smolenski R.T., Varela-Carver A., Fukushima S., et al. Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J 18 (2004) 1153-1155
19. Orbe J., Rodriguez J.A., Calvo A., Grau A., Belzunce M.S., Martinez-Caro D., et al. Vitamins C and E attenuate plasminogen activator inhibitor-1 (PAI-1) expression in a hypercholesterolemic porcine model of angioplasty. Cardiovasc Res 49 (2001) 484-492
20. Meller J., Herman M.V., and Teichholz L.E. Noninvasive assessment of left ventricular function. Adv Intern Med 24 (1979) 331-357
21. Junqueira L.C., Bignolas G., and Brentani R.R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11 (1979) 447-455
22. Nicoletti A., Heudes D., Hinglais N., Appay M.D., Philippe M., Sassy-Prigent C., et al. Left ventricular fibrosis in renovascular hypertensive rats. Effect of losartan and spironolactone. Hypertension 26 (1995) 101-111
23. Marijianowski M.M., Teeling P., Mann J., and Becker A.E. Dilated cardiomyopathy is associated with an increase in the type I/type III collagen ratio: a quantitative assessment. J Am Coll Cardiol 25 (1995) 1263-1272
24. Pouzet B., Vilquin J.T., Hagege A.A., Scorsin M., Messas E., Fiszman M., et al. Intramyocardial transplantation of autologous myoblasts: can tissue processing be optimized?. Circulation 102 (2000) III210-III215
25. Dib N., Diethrich E.B., Campbell A., Goodwin N., Robinson B., Gilbert J., et al. Endoventricular transplantation of allogenic skeletal myoblasts in a porcine model of myocardial infarction. J Endovasc Ther 9 (2002) 313-319
26. Pagani F.D., DerSimonian H., Zawadzka A., Wetzel K., Edge A.S.B., Jacoby D.B., et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. J Am Coll Cardiol 41 (2003) 879-888
27. Leobon B., Garcin I., Menasche P., Vilquin J.T., Audinat E., and Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A 100 (2003) 7808-7811
28. Winitsky S.O., Gopal T.V., Hassanzadeh S., Takahashi H., Gryder D., Rogawski M.A., et al. Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro. PLoS Biol 3 (2005) e87
29. Askari A.T., Unzek S., Popovic Z.B., Goldman C.K., Forudi F., Kiedrowski M., et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362 (2003) 697-703
30. Askari A., Unzek S., Goldman C.K., Ellis S.G., Thomas J.D., DiCorleto P.E., et al. Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy. J Am Coll Cardiol 43 (2004) 1908-1914
31. Yau T.M., Li G., Weisel R.D., Reheman A., Jia Z.Q., Mickle D.A., et al. Vascular endothelial growth factor transgene expression in cell-transplanted hearts. J Thorac Cardiovasc Surg 127 (2004) 1180-1187
32. Lee R.J., Springer M.L., Blanco-Bose W.E., Shaw R., Ursell P.C., and Blau H.M. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102 (2000) 898-901
33. Germani A., Di Carlo A., Mangoni A., Straino S., Giacinti C., Turrini P., et al. Vascular endothelial growth factor modulates skeletal myoblast function. Am J Pathol 163 (2003) 1417-1428
34. Brooks A., Schinde V., Bateman A.C., and Gallagher P.J. Interstitial fibrosis in the dilated non-ischaemic myocardium. Heart 89 (2003) 1255-1256
35. Diez J., Gonzalez A., Lopez B., and Querejeta R. Mechanisms of disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease. Nat Clin Pract Cardiovasc Med 2 (2005) 209-216
36. Querejeta R., Lopez B., Gonzalez A., Sanchez E., Larman M., Martinez Ubago J.L., et al. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis. Circulation 110 (2004) 1263-1268
37. Shigeyama J., Yasumura Y., Sakamoto A., Ishida Y., Fukutomi T., Itoh M., et al. Increased gene expression of collagen Types I and III is inhibited by {beta}-receptor blockade in patients with dilated cardiomyopathy. Eur Heart J 26 (2005) 2698-2705
38. Ciulla M.M., Paliotti R., Esposito A., Diez J., Lopez B., Dahlof B., et al. Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis: results of a randomized trial. Circulation 110 (2004) 552-557
39. D'Ascia C., Cittadini A., Monti M.G., Riccio G., and Sacca L. Effects of biventricular pacing on interstitial remodelling, tumor necrosis factor-alpha expression, and apoptotic death in failing human myocardium. Eur Heart J 27 (2006) 201-206
40. Xu X., Xu Z., Xu Y., and Cui G. Selective down-regulation of extracellular matrix gene expression by bone marrow derived stem cell transplantation into infarcted myocardium. Circ J 69 (2005) 1275-1283
41. Peters N.S. Arrhythmias after cell transplantation for myocardial regeneration: natural history or result of the intervention?. J Cardiovasc Electrophysiol 16 (2005) 1255-1257
42. Fernandes S., Amirault J.C., Lande G., Nguyen J.M., Forest V., Bignolais O., et al. Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias. Cardiovasc Res 69 (2006) 348-358